Effects of Ocrevus in Relapsing Multiple Sclerosis

计划入组 60 人 · 首次发布于 2020 年 5 月 14 日

Fecal Microbial Transplantation in Relapsing Multiple Sclerosis Patients

计划入组 14 人 · 首次发布于 2017 年 6 月 12 日

Dose-finding Study for SAR442168 in Relapsing Multiple Sclerosis

计划入组 130 人 · 首次发布于 2019 年 3 月 26 日

Siponimod(Mayzent 0.25 Mg Starter Pack, Mayzent)

C₂₉H₃₅F₃N₂O₃ · Rx

Ponesimod(Ponvory)

C₂₃H₂₅ClN₂O₄S

Multiple Sclerosis(Progentos)

National Multiple Sclerosis Society

United States

MULTIPLE SCLEROSIS CENTER OF CALIFORNIA

United States

Accelerated Cure Project Inc

United States

Kesimpta Demonstrates Sustained Efficacy in Relapsing Multiple Sclerosis

Biogen Completes Phase 2 Trial of BIIB091 for Relapsing Multiple Sclerosis

Rituximab Shows Long-Term Effectiveness with Extended Dosing Intervals in Relapsing Multiple Sclerosis